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Effects of Structure on Binding to the
2,3,7,8-TCDD Receptor Protein and AHH
Induction Halogenated Biphenyls
by Stephen Safe*, Stelvio Bandiera,* Tom Sawyer,* Bozena
Zmudzka,* Grant Mason,* Marjorie Romkes,t Mary Anne
Denomme,t Judy Sparling,t Allan B. Okey,* and Toshio
Fujita§
Thequantitative structure-activityrelationships (QSARs) forpolychlorinated biphenyl(PCB)congeners
have been determined by comparing the ECQ, values for three in vitro test systems, namely, aryl hydro-
carbon hydroxylase (AHH) and ethoxyresorufin O-deethylase (EROD) induction in rat hepatoma H-4-II-
E cells and competitive binding avidities to the rat cytosolic receptor protein (using 2,3,7,8-tetrachloro-
dibenzo-p-dioxin as a radioligand). For several PCB congeners that are in vivo inducers of rat hepatic
microsomal AHH, there was a linear correlation between the -logEC.4 values for receptorand&the -log
ECso values for AHH (or EROD) induction; moreover, a comparable linear relationship was observed
between the -log EC.4 values for AHH and EROD induction. Previous in vivo studies have shown that
the most active PCB congeners 3,3',4,4'-tetra-, 3,4,4',5-tetra-, 3,3',4,4',5-penta-, and 3,3',4,4',5,5'-hexa-
chlorobiphenyl, cause many ofthe biologic and toxic effects reported for the highly toxic halogenated aryl
hydrocarbon, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Moreover, the monoortho-substituted homologs
ofthe four coplanar PCBs also elicit comparable in vivo biologic and toxic responses. It was evident from
the QSARs for PCBs that there was an excellent correspondence between the in vivo and in vitro potencies
of the individual PCB congeners.
The effects of substituents on both receptor binding and AHH/EROD induction was determined for a
series of4'-substituted (X)-2,3,4,5-tetrachlorobiphenyls (where X = H, Cl, Br, I, OH, OCH,, NO2, COCH3,
F, CF3, CH3, C2HA, i-C3H7, n-C4H, and t-C4H,). Not unexpectedly, there was a linear relationship between
the-logECsovaluesforAHHandERODinduction, andtheseresultsconfirmthatbothenzymaticoxidations
are catalyzed by the same cytochrome P-450 isozyme(s). The effects of substituent structure on receptor
binding for 12 substituents was subjected to multiple regression analysis which correlates the relative
binding affinities of the compounds with the physical chemical characteristics of the substituents. The
analysis gave the following equation: log (1/EC,0) = 1.53a + 1.47Th + 1.09 HB + 4.08 for n = 12, s =
0.18, r = 0.978; where n is the number of substituents, s is the standard deviation, r is the correlation
coefficient, and af = electronegativity, -T = hydrophobicity (logP) and HB = hydrogen bonding capacity
for the substituent groups. The data suggest that the latter three parameters facilitate the interaction
between.the ligand and the cytosolic receptor protein. The effects of two lateral substituents on ligand-
receptor interactions are not readily explained by the above relationship and may depend on other sub-
stituent physical chemical parameters.
Introduction
Pharmacogenetic studies have played an important
role in understanding the biologic and toxic effects of
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carcinogens, drugs and related xenobiotics. Nebert and
co-workers have investigated the toxic, carcinogenic,
and biologic activities of polynuclear aromatic hydro-
carbons (PAHs) in genetically inbred mice strains, and
their results have suggested a mechanism ofaction for
these compounds (1-4). The activity of 3-methylchol-
anthrene (3-MC) and several related PAHs as inducers
ofhepatic and extrahepatic drug-metabolizing enzymes
is remarkably dependent on the strain of mice used.
Hepatic microsomal aryl hydrocarbon hydroxylase
(AHH), a cytochrome P-448-dependent monooxygen-
ase, is readily induced by 3-MC in several strains ofSAFE ET AL.
mice, typified by the "responsive" C57BL/6J strain; in
contrast, 3-MC does not induce AHH in nonresponsive
strains, typified by the DBA/2J mice (5,6). Moreover,
responsive mice are more susceptible than nonrespon-
sive mice to the toxic (inflammation, fetotoxicity, pri-
mordial oocyte depletion) and carcinogenic effects of
PAHs at organs/tissues in direct contact with the ap-
plied PAHs (1-13). The gene complex responsible for
mediating the effects ofPAHs has been designated the
Ah locus which may comprise regulatory, structural,
and possibly temporal genes. Extensive studies on ge-
neticallyinbredresponsive andnonresponsivemice (and
their backerosses) suggests that the differences in sus-
ceptibility are related to the levels oftheAh regulatory
gene product, the cytosolic Ah receptor protein. The
receptor protein interacts with the PAH ligands and
theresultantPAH:receptorligandcomplextranslocates
into the nucleus and presumably initiates the toxic and
biologic effects via a process comparable to that pro-
posed for the steroid hormones (1-6).
Genetic, biochemical and toxicologic studies also sup-
port the role of the Ah receptor protein in mediating
the effects of2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
(14-17). For example, competitive binding studies with
radiolabeled and unlabeled 2,3,7,8-TCDD and 3-MC
confirms thatboth compoundsbindtothe samereceptor
protein (18). The murine Ah receptor concentrations in
C57BL/6J mice vary from 45 to 75 fmole/mg cytosolic
protein, whereas this protein is not detected in the cy-
tosolofDBA/2J mice (note: nuclearreceptorlevels have
been detected in this mouse strain) (18-20). 2,3,7,8-
TCDD induces AHH and causes cleft palate, a wasting
syndrome, immunotoxicity and thymic atrophy in re-
sponsive C57BL/6J mice; some of these effects are ob-
served in the nonresponsive DBA/2J mice but only at
relatively high dose levels (14-17, 21-23). Backcross
experiments with DBA/2J and C57BL/6J mice give re-
sults consistent with the segregation of the activity of
2,3,7,8-TCDD with the Ah locus (16,17,21,23,25,26).
There are marked effects ofstructure on the activity of
polychlorinated dibenzo-p-dioxins (PCDDs); the most
active compound, 2,3,7,8-TCDD, is substituted at all
fourlateral positions. Moreover, the addition ofCl groups
or the removal of lateral substituents tends to reduce
the activity oftheresultant congeners (17,21,22,26-29).
Several halogenated aromatic compounds, such as
2,3,7,8-tetrachlorodibenzofuran (TCDF), 3,3',4,4',5,5'-
hexabromo- and hexachlorobiphenyl, which are approx-
imate isostereomers of 2,3,7,8-TCDD, exhibit similar
toxic and biologic activities (17,21,29-37).
The results obtained for the toxic halogenated aro-
matics show a correlation between the toxicity of an
individual compound, its receptor binding avidity, and
potency as an inducer of AHH. These results support
the role of the Ah receptor in mediating many of the
toxic and biologic responses elicited by this class of
chemicals.
Polychlorinated Biphenyls (PCBs)
and Polybrominated Biphenyls
(PBBs)-QSAR
PCBs
Invivo structure-activity relationships developed for
PCB congeners show that the most active compounds,
3,3',4,4'-tetra-, 3,3',4,4',5-penta-, and 3,3',4,4',5,5'-
hexachlorobiphenyl, elicit toxic and biologic effects which
are comparable to those observed after treatment with
2,3,7,8-TCDD. These compounds are potent inducers of
AHH and ethoxyresorufin O-deethylase (EROD)insev-
eral mammalian species and induce cytochromes P-450c
and P-450d in male Long-Evans rats (38-43). Although
extensive toxicity studies have not been reported for
all three congeners, it is apparent that one or more of
these PCBs elicit the following toxic effects; a wasting
syndrome, thymic atrophy, hepatic damage, reproduc-
tive toxicity, differential effects on genetically inbred
C57BL/6J and DBA/2J mice, porphyria, immunotoxic-
ity, and dermal toxicity (42,44-51).
Studies in our laboratory have shown that all the
mono-ortho analogs ofthe 3,3',4,4'-tetra-, 3,4,4',5-tetra-,
3,3',4,4',5-penta- and 3,3,4,4,5,5'-hexachlorobiphenyls
alsoinducehepaticmicrosomalAHH and ERODinmale
Wistar rats and C57BL/6J mice. However, in contrast
to the highly toxic coplanar PCBs, these compounds
resemble phenobarbitone (PB) plus 3-MC (coadminis-
tered) as inducers of hepatic microsomal drug-metab-
olizing enzymes (42,52,53). Despite this apparent
bifunctional or "mixed-type" enzyme induction activity,
there is evidence in the literature that many of these
compounds also cause toxic effects similar to those ob-
served after treatment with 2,3,7,8-TCDD. For ex-
ample: 2,3',4,4',5-penta-, 2,3,3',4,4'-penta-, 2,3,3',4,4',5-
hexa-, and 2,3,3',4,4',5'-hexachlorobiphenyl cause
thymic atrophy in rats (50). 2,3,3',4,4'-Pentachlorobi-
phenyl administered to mice and rats results in a wast-
ing syndrome (weight loss), edema, liver lipid
accumulation, extensive hepatic damage, and splenic
atrophy (54); 2,3',4,4',5-pentachlorobiphenyl causes
100% embryo mortality in eggs from pullets receiving
the PCB in their diet at a level of20 ppm (55); admin-
istration of 2,3',4,4',5-penta- and 2,3,3',4,4',5-hexa-
chlorobiphenyl to rats caused increased liver weights,
increased liver lipids and thymic atrophy (56). These
dataindicate that at leastfive ofthe mono-orthoanalogs
of the coplanar PCBs elicit toxic effects that qualita-
tively resemble those observed after treatment with
2,3,7,8-TCDD.
The in vivo structure-activity relationships (SARs)
provide qualitative support for the proposed receptor-
mediated hypothesis for the mechanism of action of
2,3,7,8-TCDD and related toxic halogenated aryl hy-
drocarbons. Quantitative structure-activity relation-
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FIGURE 1. Sucrose density gradient analysis after incubation of 10
nM [3H]-2,3,7,8-TCDD with the rat cytosolic receptor protein and
no competitor; 10 1±M 2,3,7,8-TCDD, 10 ,uM 3-MC, and 10 ,M PB.
ships (QSARs) for the PCBs have been obtained by
using interrelated bioassays systems, namely, the com-
petitive binding affinities ofPCBs forthe2,3,7,8-TCDD
hepatic cytosolic receptorprotein frommale Wistarrats
(57) and the AHH and EROD induction potencies of
these compounds in rat hepatoma H-4-II-E cells in cul-
ture (34). The former assay measures the important
interaction between the toxin orligand andthe receptor
protein, whereas the induction assay measures one of
the biologic consequences (i. e., the induction of cyto-
chrome P-448-dependent monooxygenases ofthis initial
interaction). Dose-response studies are also readily de-
termined by using in vitro assays, and the pharmaco-
kinetic and metabolic factors which play arole in in vivo
studies are minimized.
The QSAR for the binding avidities of PCBs to the
cytosolic receptor protein have been reported by using
the sucrose density gradient assay system (57). Figure
1 illustrates the [3H]-2,3,7,8-TCDD-receptor protein
binding peak which sedimented at approximately frac-
tion 25 and corresponded to a sedimentation rate of 8-
10S (dependent on ionic concentration of the buffer).
Competition experiments with 10 ,uM nonradiolabeled
2,3,7,8-TCDD or 3-MC completed eliminated this peak,
whereas competition experiments with PB did not sig-
nificantly decrease the area of this radioactive binding
peak. Figure 2 illustrates the sucrose density gradient
proffles observed after competive binding experiments
2000 F
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FIGURE 2. Sucrose density gradient analysis after incubation with
10 nM rH]-2,3,7,8-TCDD with the rat cytosolic receptor protein
and 10 ,uM 3,3',4,4',5'-penta-, 2,3,3',4,4'-penta-, and 2,2',4,4'-
tetrachlorobiphenyl.
of the cytosolic receptor protein-rH]-2,3,7,8-TCDD
complex with 10 ,uM 3,3',4,4',5-pentachlorobiphenyl and
2,3',4,4',5- and 2,2',4,4'-tetrachlorobiphenyl. The highly
toxic 3-MC-type inducer, 3,3',4,4',5-pentachlorobi-
phenyl, completely eliminates the radiolabeled binding
peak, whereas the less toxic mixed-type inducer only
partially reduces the area of this peak. Although
2,2',4,4'-tetrachlorobiphenyl is a relatively nontoxic PCB
congener that strictly resembles PB in its mode of in-
duction ofthe hepatic microsomal monooxygenases, this
compound does competitively displace some of the ra-
diolabeled 2,3,7,8-TCDD. Dose-response-competition
experiments with several other PCB congeners that do
not induce AHH (i.e., 2,3,4,5-tetra- and 2,2',4,4',5,5'-
hexachlorobiphenyl) showed that athigh concentrations
there is some competition with [3H]-2,3,7,8-TCDD for
the receptor bindingprotein. The biological significance
of this weak binding has not been determined.
Table 1 summarizes the binding avidities of 14 PCBs,
and the data complement the results illustrated in Fig-
ure 1; the coplanar PCBs are the most avid competitors
for binding to the receptor protein; the monoortho-sub-
stituted analogs of the coplanar PCBs also bind to the
receptorbutwithloweraffinities thanthe coplanar com-
pounds. These in vitro data parallel the in vivo SAR
for PCBs and confirm that the most active compounds
are substituted in both para and two or more meta
positions and that the introduction of a single ortho sub-
0-C- 10 nM [3H]TC DD
with 1OPM 33445- PCBP
-W with 10pM 2.3,4,4,5- PCBP
-4 with lOpM 2.2.4.4-TCBP
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Table 1. PCBs: a comparison ofthe effects ofstructure on their cytosolic receptor binding avidities and AHH/EROD induction potencies.
-log EC50
Receptor AHH EROD
PCB congener No. binding induction induction
3,3',4,4'5-Penta 1 6.89 9.62 9.61
3,3',4,4'-Tetra 2 6.15 7.55 7.05
2,3,4,4',5-Penta 3 5.39 6.02 6.25
2,3,3',4,4'-Penta 4 5.37 7.06 6.92
2,3,3',4,4',5'-Hexa 5 5.33 6.15 5.90
Aroclor 1254 5.22 5.42 5.34
2,3,3',4,4',5-Hexa 6 5.15 5.68 6.05
2,3',4,4',5-Penta 7 5.04 4.94 5.05
2',3,4,4',5-Penta 8 4.85 5.41 5.95
2,3',4,4',5,5'-Hexa 9 4.80 4.88 5.05
2,3,4,4'-Tetra 10 4.55 4.96 5.72
2,2',4,4',5,5'-Hexa 11 4.10
2,3',4,4',5', 6-Hexa 12 4.00
2,2',4,4'-Tetra 13 3.89
2,3,4,5-Tetra 14 3.85
PB
3-MC 7.60 5.89 6.20
TCDD 8.00 10.02 10.10
stituent into the biphenyl ring diminishes but does not
eliminate the activity ofthe resultant compounds.
Table 1 also summarizes the effects of structure on
the activity ofPCBs as inducers ofAHH and EROD in
rat hepatoma H-4-II-E cells in culture. A plot ofrecep-
tor binding affinities versus AHH or EROD induction
potencies(Figs. 3and4)illustratesthelinearcorrelation
between these two biologic parameters and thus sup-
ports the role ofthe receptor in mediatingthe induction
ofthe cytochrome P-448-dependent monooxygenases.
PBBs
In vivo studies with purified PBB congeners indicate
that their biologic and toxic properties and the effects
of structure on activity are comparable to those ob-
served for the PCBs. The coplanar PBBs substituted
in both para and two or more meta positions are highly
toxic (29,42,58-61), induce microsomal AHH and the
associated cytochrome P450 isozymes in rats (42,60,62),
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and elicit differential biologic and toxic effects in ge-
netically inbred C57BL/6J and DBA/2J mice (50). More-
over, many of the monoortho analogs of the coplanar
PBBs are mixed-type inducers (i.e., inducers of cyto-
chromes P-450a-P-450e) (42,60,62-65) and also cause
some ofthe toxic effects observed for the coplanar con-
geners (42,63-66). A detailed in vitro QSAR analysis
has not been reported for PBB congeners; however,
both 3,3',4,4',5,5'-hexa- and 3,3',4,4'-tetrabromobi-
phenyl competitively displace radiolabeled 2,3,7,8-TCDD
from the cytosolic receptor protein (29,58). Figure 5
illustrates the sucrose density gradient analysis ob-
tained after incubation of [3H]-2,3,7,8-TCDD with rat
hepatic cytosol and selected PBB congeners. Like the
PCBs, the coplanar 3,3',4,4',5-pentabromobiphenyl
completely displaces the radiolabel, the 2,3,3',4,4',5'-
hexabromobiphenyl partially displaced the radiolabel
whereas 2,2',5,5'-tetrabromobiphenyl, arelatively non-
toxic congener that does notinduce AHH, was the least
active competitor. These results were similar to those
reported for the PCBs.
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FIGURE 3. Plot of the -log EC. values of the receptor binding
avidities vs. AHH induction potencies for a series ofPCB isomers
and congeners (Table 1).
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-log EC50 (EROD)
FIGURE 4. Plot of the -log ECN values of the receptor binding
avidities vs. ERODinductionpotenciesforaseriesofPCB isomers
and congeners (Table 1).
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FIGURE 5. Sucrose density gradient analysis after incubation with
10 nM [3H]-2,3,7,8-TCDD and 10 ,uRM 3,3',4,4',5-penta-,
2,3,3',4,4',5'-hexa-, and 2,2'5,5'-tetrabromobiphenyl.
Andres and co-workers (61) recently compared the
biologic and toxic effects of a series of 3,3',4,4'-tetra-
halobiphenyls that differed in their Br/Cl ratios. It was
apparent that for the in vivo studies the most active
and least active compounds were the 3,3',4,4'-tetra-
bromo- and 3,3',4,4'-tetrachlorobiphenyls, respec-
tively. The effects of Br versus Cl were more
dramatically illustrated by the comparison of in vitro
receptor binding affinities and AHH/EROD induction
potenciesin rathepatoma H-4-II-E cells inculture (Fig.
6). The QSAR studies clearly illustrate a linear rela-
tionship between the binding and induction parameters
and support therelationship between these two effects.
It is also evident that for the 3,3',4,4'-tetrahalobiphen-
yls, bromo substituents facilitate ligand-receptor bind-
ing more than chloro groups. The reason for these
substituenteffects are discussed inthefollowingsection.
Substituted Halogenated Biphenyls
The in vivo and in vitro studies with structurally
diverse PCBs and PBBs support a common receptor-
mediated mechanism of action for halogenated biphen-
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FIGURE 6. Plot of the - log EC,, values of the receptor binding
avidities vs. AHH and EROD induction potencies for a series of
3,3',4,4'-tetrahalobiphenyls.
yls, PCDDs and PCDFs. Despitethe criticalrole played
by the Ah receptor protein in the biochemistry and tox-
icology ofhalogenated aromaticsand PAHs, thisprotein
has not been purified from any species. However, the
nature of the protein binding sites for halogenated ar-
omatics have been studied by several groups, and their
results indicate the following.
Based on the high binding affinity of2,3,7,8-TCDD, a
ligand should be relatively flat or planar, and deviations
fromthisstructuralfeature (e.g., monoortho-substituted
halogenated biphenyls) result in diminished binding af-
finities (21,26,36) ofthe ligands. The optimal two-dimen-
sional shape ofaligand corresponds to a3 x 10 Arectangle
(17,21,37). Maximum binding affinity requires the sub-
stitution ofCl at all four lateral positions for the PCDDs
and PCDFs or at four to six lateral positions for PCBs
and PBBs (17,21,37,57). Bromo-substituted biphenyls and
PCDDs exhibit higher binding affinities than their chlor-
inated analogs (61,67,68). Polarizability and the electron-
acceptor properties of the lateral substituents are pro-
posed to be important properties which facilitate binding
to the receptor (69-71).
Substituent effects on the activity of chemicals are
routinely determined to facilitate the design of active
drugs and agriculturalchemicals. This approach can also
be used to study the effects of substituents on the in-
teraction of halogenated aromatics with the 2,3,7,8-
TCDD receptor protein. The model compounds chosen
for this study were a series of 4'-substituted-2,3,4,5-
tetrachlorobiphenyls. The PCB member of this series,
2,3,4,4',5-pentachlorobiphenyl, is a mixed-type inducer
of microsomal monooxygenases and exhibits many of
the properties characteristic of 2,3,7,8-TCDD and re-
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FIGURE 7. In vivo AHH, EROD, and N-DMAP induction potencies of4'-substituted 2,3,4,5-tetrachlorobiphenyls (300 ,umole/kg) in immature
male Wistar rats.
lated toxic halogenated aromatics. 2,3,4,4',5-Penta-
chlorobiphenyl (PCBP) induces microsomal AHH and
EROD in male Wistar rats (33), C57BL/6J mice (72),
and rat hepatoma H-4-II-E cells in culture (34) and in-
duces cytochromes P-450c and P-450d in male Long-
Evans Rats (42); PCBP also binds to the rat hepatic
cytosolic 2,3,7,8-TCDD receptor protein (57). In addi-
tion, PCBP causes thymic atrophy in rats and C57BL/
6J mice but does not induce AHH or cause thymic atro-
phy in DBA/2J mice (72). Substitution at the 4' lateral
position is important for the activity of this group of
halogenated biphenyls, since 2,3,4,5-tetrachlorobi-
phenyl, the unsubstituted homolog (4'=H), is a poor
ligand for the receptor (57), does not induce AHH or
EROD, and is relatively nontoxic.
The effects of 14 different 4'-substituted-2,3,4,5-tet-
rachlorobiphenyls as inducers ofrat hepatic microsomal
monooxygenases aresummarized inFigure 7. Theinvivo
activity of these compounds as inducers of microsomal
AHH, EROD and DMAP N-demethylase were remark-
ably dependent on the structure of the 4'-substituent.
The 4'-iodo-2,3,4,5-tetrachlorobiphenyl was the most po-
tent inducer of AHH and EROD; however, the 4'-bromo-,
4'-chloro-, 4'-trifluoromethyl, 4'-nitro-,4'-cyano-, 4'-tert-
butyl-, 4'-isopropyl-, 4'-fluoro-, 4'-phenyl-, 2,3,4,5-tet-
rachlorobiphenyls also significantly induced both cyto-
chrome P-448-dependent monooxygenases. There were
also substituent effects on the activity of these com-
pounds as inducers of DMAP N-demethylase; the chloro-,
bromo-, fluoro-, nitro-, and cyano-substituted PCBs were
inducers, whereas the 4'-trifluoromethyl-, 4'-iodo-, 4'-
isopropyl-, and 4'-tert-butyl-2,3,4,5-tetrachlorobiphenyls
were inactive. A second group of4'-substituted 2,3,4,5-
tetrachlorobiphenyls, namely the 4'-acetyl-, 4'-methyl-,
and 4'-hydroxy-2,3,4,5-tetrachlorobiphenyls and 2,3,4,5-
tetrachlorobiphenyl do not induce any ofthe cytochrome
P-450-dependent monooxygenases. The rationale for the
effects ofsubstituents on the in vivo microsomal mono-
oxygenase enzyme-inducingactivitiesofthesubstituted
PCBs is not apparent: One possible explanation forthese
differences in activity may be associated with hepatic
residue levels of these compounds. The results summa-
rized in Table 2 clearly show that the most active AHH
and EROD inducers persist in the liver at concentrations
which range from 36.34 to 17.04 ppm. However, 4'-iso-
propyl-, 4'-tert-butyl- and 4'-phenyl-2,3,4,5-tetrachloro-
biphenyl also significantly induce AHH and EROD and
their hepatic levels are in the range of 1 to 4 ppm. Al-
though residue levels may play a role in the in vivo po-
tencies of the 4'-substituted-2,3,4,5-tetrachlorobiphenyls,
it is probable that many factors (e. g., metabolic rates)
including the substituent properties are important de-
terminants for the in vivo activities.
The quantitative effects ofthe 4'-substituents on ac-
tivity are morereadilyassessedusingtheinvitro bioas-
says (73) since these procedures minimiize the importance
ofmetabolic and pharmacokinetic factors. Table 3 sum-
marizes the -log EC,0 values for the receptor binding
avidities, AHH and EROD inductionpotencies forthir-
teen 4'-substituted-2,3,4,5-tetrachlorobiphenyls.
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Table 2. Comparative concentrations of 4'-substituted 2,3,4,5-
tetrachlorobiphenyls in rat liver.a
Treatment
4'-Iodo-2,3,4,5-tetrachlorobiphenyl
4'-Bromo-2,3,4,5-tetrachlorobiphenyl
2,3,4,4',5-Pentachlorobiphenyl
4'-Fluoro-2,3,4,5-tetrachlorobiphenyl
4'-Hydro-2,3,4,5-tetrachlorobiphenyl
4'-Methyl-2,3,4,5-tetrachlorobiphenyl
4'-Ethyl-2,3,4,5-tetrachlorobiphenyl
4'-Isopropyl-2,3,4,5-tetrachlorobiphenyl
4'-Butyl-2,3,4,5-tetrachlorobiphenyl
4'-Butyl-2,3,4,5-tetrachlorobiphenyl
4'-Phenyl-2,3,4,5-tetrachlorobiphenyl
4'-Trifluoromethyl-2,3,4,5-tetrachlorobiphenyl
4'-Cyano-2,3,4,5-tetrachlorobiphenyl
4'-Hydroxy-2,3,4,5-tetrachlorobiphenyl
4'-Methoxy-2,3,4,5-tetrachlorobiphenyl
4'-Acetyl-2,3,4,5-tetrachlorobiphenyl
4'-Nitro-2,3,4,5-tetrachlorobiphenyl
4'-N-Acetylamino-2,3,4,5-tetrachlorobiphenyl
Residue levels,
ppm
72.08 10.33
171.04 12.89
55.53 13.27
36.68 1.63
0.429 0.208
0.385 0.251
3.98 ± 2.94
1.16 ± 0.07
3.01 ± 0.32
2.41 ± 1.85b
3.14 ± 0.07
58.41 ± 7.17
36.34 ± 1.55
NDC
2.63 ± 1.40
not determined
101.34 ± 66.63
not determined
Number of
animals per
group, n
3
3
4
3
3
4
4
3
3
3
3
3
3
4
3
3
4
4
aAninals were injected intraperitoneally on days 1 and 3 with the 4'-substituted 2,3,4,5-tetrachlorobiphenyls (dissolved in corn oil) at dose
levels of 150 ,umole/kg per injection and kIlled on day 6.
bResidue levels of this compound in adipose tissue were 325.07 ± 188.36 (n = 4).
CND = non-detectable.
Table 3. 4'-Substituted-2,3,4 *tetrachlorobiphenyls: effects of substituents on their cytosolic receptor binding avidities and AHH/EROD
induction potencies.a
-log EC50
Receptor AHH EROD
4'-Substituted (X)-2,3,4,5-tetrachlorobiphenyls No. binding induction induction
X = CF3 1 6.43 8.42 8.62
X = i-C3H7 2 5.89 6.35 6.74
X= I 3 5.82 7.96 7.68
X = Br 4 5.60 7.52 7.28
X = C2H5 5 5.46 5.47 5.31
X = Cl 6 5.33 5.41 5.96
X = CN 7 5.27 4.85 5.05
X = COCH3 8 5.17 5.45 5.43
X = OCH3 9 4.80 4.59 4.52
X = F 10 4.60 4.57 4.72
X = CH3 11 4.51 4.82 4.89
X = OH 12 4.05 4.0 4.0
X = H 13 3.85 4.0 4.0
a"1ken from Bandiera et al. (73).
From inspection ofthe results ofcompetitive binding
experiments (Table 3), it is apparent that some substi-
tuent groups enhance the binding of 4'-substituted-
2,3,4,5-tetrachlorobiphenyls relative to that of2,3,4,4',5-
pentachlorobiphenyl (i. e., 4'-chloro-2,3,4,5-tetrachlo-
robiphenyl), while others diminished it. The relative
competitive potency ofthe 4'-substituted 2,3,4,5-tetra-
chlorobiphenyls followed the order CF3> CH(CH3)2
> I > Br > CH2CH3> Cl forthe most effective ligands.
In fact, 4'-trifluoromethyl-2,3,4,5-tetrachlorobiphenyl
(i. e., 4'-CF3 derivative) competed with [3H]-2,3,7,8-
TCDD forthe specific bindingsites almost as effectively
as 3,3',4,4',5-pentachlorobiphenyl, the most potent
competitor ofall the PCBs previously tested. The find-
ing that both the 4'-ethyl and 4'-isopropyl compounds
were active competitors for the receptor indicates that
halogen substitution in both phenyl rings is not a re-
quirement for binding.
Since the ability to bind effectively to the cytosolic
receptor is either enhanced or reduced by various sub-
stituent groups on the tetrachlorobiphenyl backbone,
the variation in biological activity must be dependent
on the properties inherent in the substituents. Quan-
titative analysis of substituent structure-activity ef-
fects can be used to study the intermolecular interactions
betweenligands and theirreceptors (74-77). Ingeneral,
drug-receptor interactions involve such forces as hy-
drophobic bonding, hydrogen bonding, van der Waals
energy, electrostatic energy, valence-bond energy, and
repulsion or strain energies of the bonds (77). The
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strength ofthe interaction depends upon the use ofthese
various energies, which for a series of substituted con-
geners, can be approximated by the use offree-energy-
related physiochemical substituent parameters (74-78).
For the present series of 4'-substituted tetrachlorobi-
phenyls, the relationships between various substituent
parameters and receptor binding constants were ex-
amined by means ofmultiparameter regression analysis.
Foreach substituent group, ahydrophobic parameter
,Tr, an electronic parameter a, and a hydrogen-bonding
accepting parameter HB were determined. The hydro-
gen-bonding parameter HB is an indicator variable that
takes a value of unity for substituents which are hy-
drogen acceptors but a value of zero for nonhydrogen-
bonders. For the electronic effect of 4'-substituents,
upara (Hammett constant) was used. The up values were
obtained from the literature.
The hydrophobic parameter wr, defined as
rr = log Px - log PH
where Px and PH are the partition coefficients of 4'-
substituted-2,3,4,5-tetrachlorobiphenyl and 4'-unsub-
stituted-2,3,4,5-tetrachlorobiphenyl, respectively, in the
n-octanollwater system, was estimated by means of a
recently developed method (79). According to this
method, -T values for the hydrogen-bondable 4'-substi-
tuents were calculated by using the equation:
'UX/C6H4C6HCk4 = O.961TX/C6H5 + 0.19 PX (2)
where the subscript X/C6H4C6HC14, denotes wr values
for the 4'-substituted-2,3,4,5-tetrachlorobiphenyls and
the subscript X/C6H5 refers to values for monosub-
stituted benzenes. As Eq. (2) illustrates, hydrophobic
substituent parameters (IT) were derived from values
for monosubstituted benzenes. This derivation is valid
because 4'-substituted-2,3,4,5-tetrachlorobiphenyl can
be considered as a special case of a para-disubstituted
benzene in which one ofthe substituent groups remains
constant while the other is variable. The ir values for
disubstituted benzenes have been calculated using pa-
rameters from monosubstituted benzenes (79). The fac-
tor 0.19px, describes the solubility-modifying effect of
theelectron-withdrawing2,3,4,5-tetrachlorobiphenyl
group on the hydrogen-bonding interaction of each 4'-
substituent with solvents. For substituents incapable
of hydrogen bonding, such as alkyl and halogen, the p
value is zero. The electron-withdrawing effect of the
2,3,4,5-tetrachlorobiphenyl group can be expressed by
the cp value, which was estimated as U,p/C6Cc5 X 4/5 =
0.19. The 1MX/c6H, values were taken from the literature.
For 15 compounds ofthe present series ofpara-sub-
stituted biphenyls, electronic, hydrophobic and hydro-
gen-bonding substituent constants were examined with
respect to the EC,, values calculated from competition
binding assays (shown in Table 4). Multiple regression
analysis of the data led to Eq. (3):
log(1/ECO) = 1.39u + 1.31-rr + 1.12HB + 4.20 (3)
(0.57) (0.43) (0.61) (0.39)
with n = 15, s = 0.31, r =0.916, F = 19.20 (a<1%),
in which hydrophobic wr, electronic cr, and a variable HB
for hydrogen bond formation are significant parameters
determining the variations in binding constants. The
Table 4. Substituent parameters and analysis of binding constants.
log(I/EC50)
4'-Substituent X/CCH5b pxPc x/C6H4C6HC14 ( HB Obs Calcd
H 0 0 0 0 0 3.85 4.20 -0.35
OH -0.67 0.94 -0.46 -0.37 1 4.05 4.20 -0.15
CH3 0.56 0.54 -0.17 0 4.51 4.67 -0.16
F 0.14 0 0.13 0.06 0 4.60 4.45 0.15
OCH3 -0.02 0.27 0.03 -0.27 1 4.80 4.98 -0.18
COCH3 -0.55 0.16 -0.50 0.50 1 5.17 5.36 -0.19
CN -0.57 0 -0.55 0.66 1 5.27 5.52 -0.25
Cl 0.71 0 0.68 0.23 0 5.33 5.41 -0.08
CH2CH3 1.02 0 0.98 -0.15 0 5.46 5.27 0.19
Br 0.86 0 0.83 0.23 0 5.60 5.61 -0.01
I 1.12 0 1.08 0.18 0 5.82 5.86 -0.04
CH(CH3)2 1.53 0 1.47 -0.15 0 5.89 5.92 -0.03
CF3 0.88 0 0.85 0.54 0 6.43 6.06 0.37
NO2 -0.28 -0.14 -0.30 0.78 oe 4.85 4.89 -0.04
NHCOCH3 -0.97 0.91 -0.76 0 1 5.09 4.32 0.77
C6H5 1.96 0 1.88 -0.01 0 5.18' 6.65 -1.47
C(CH3)3 1.98 0 1.90 -0.20 0 5.17f 6.41 -1.24
CH2)3CH3 2.08 0 1.99 -0.16 0 5.13f 6.59 -1.46
aData from Bandiera et al. (73) except as noted. bTaken from Hansch and Leo (80).
CTaken from Fujita (79).
dCalculated by first correlation equation (n = 15).
eSee text.
fNot included in either correlation equation.
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FIGURE 8. Plot of the -log EC. values of the receptor binding
avidities vs. AHH induction potencies foraseries of4'-substituted
2,3,4,5-tetrachlorobiphenyls (Table 3).
number of compounds is given by n, s is the standard
deviation, r is the correlation coefficient, and F is the
value ofthe F-ratio. The figures in parentheses are the
95% confidence intervals. The results ofthe analysis are
shown in Table 4.
The log (1/ECQ) for the 4'-N-acetylamino derivative
was most poorly predicted by the Eq. (3). For the 4'-
nitro compound, the HB value was taken as zero al-
thoughthenitrogroupiscapable ofactingasahydrogen
acceptor. With an HB value of unity, its affinity was
predicted to be about ten times higher than the ob-
served value. The hydrogen-bonding interaction may
not be insignificant for this compound although the
mechanism is not clear.
The analysis wasrepeated withexclusion ofthesetwo
outliers, to yield Eq. (4):
log(1IECO) = 1.53a + 1.47T + 1.09HB + 4.08 (4)
(0.37) (0.30) (0.41) (0.26)
with n = 12, s = 0.18, r = 0.978, F = 65.90 (a <
0.01%). Although the quality ofthe correlation is much
improved, the inferences drawnfromthecorrelation are
not significantly changed.
The 4'-n-butyl, 4'-tert-butyl and 4'-phenyl com-
pounds were not included in these correlations. Their
log(1/EC.) values were much lower than those pre-
dicted by the two correlation equations. The van der
Waals volumes ofthese three substituents were among
the highest, being 41.8 cm3/mole for the n-butyl/ and
tert-butyl groups and 45.8 cm3/mole for phenyl. The value
for other substituents used here was less than 35 cm3/
mole (i.e., 34.12 cm3/mole for isopropyl and 33.23 cm3/
mole for N-acetylamino). Although the use of various
types of steric parameters did not produce meaningful
correlations, there seems to be a certain limiting size
in the receptor binding site(s) to accommodate the bi-
phenyl derivatives.
The correlation (developed in the above equations)
means that both increasing substituent electron with-
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FIGURE 9. Plot of the - log EC. values of the receptor binding
avidities vs. EROD induction potencies for a series of 4'-substi-
tuted 2,3,4,5-tetrachlorobiphenyls.
drawing activity and hydrophobicity, increased binding
avidity ofthe ligands for the receptor. Hydrogen bond-
accepting substituents also favorthis binding. The coef-
ficient of the HB term, 1.10, means that the molarity
of the hydrogen donor in the receptor region is 12- to
13-foldthat ofthe octanolphasewhichisusedas amodel
of the hydrophobic receptor binding site (81).
The linearrelationship between the AHH and EROD
induction EC,0 values can be expressed by Eq. (5):
log RA (EROD) = 0.983 log RA (AHH) - 0.539
(+0.180) (+0.235)
(5)
with n = 14, s = 0.391, r = 0.960. where RAis relative
activity, n = number of substituents, s = standard
deviation, and r = correlation coefficient. Omitting the
data for the noninducers (with estimated EC50 values
for induction), 4'-hydroxy-2,3,4,5-tetrachlorobiphenyl
and 2,3,4,5-tetrachlorobiphenyl, Eq. (5) becomes:
log RA (EROD) = 0.942 log RA (AHH) - 0.434
( 0.125) (± 0.176)
(6)
with n = 12, s = 0.259, r = 0.983.
The linear correspondence between the relative ac-
tivities ofthese two induced enzyme activities provides
strong evidence that both enzymes are induced via the
same mechanism and that the oxidation of both sub-
strates is catalyzed by the same cytochrome P-450
isozymes.
Equation(7)hasbeendevelopedtorelatethereceptor
binding affinities to the AHH induction potencies ofthe
substituted halogenated biphenyls:
log RA (AHH) = 2.132 log (1/EC50)
(± 0.763)
+ 5.659 AB5 - 2.042 (AB5)2 - 14.148 (7)
(± 5.349) (± 1.802) (± 5.069)
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FIGURE 10. Sucrose densitH iiadient analysis after incubation with
10 nM [H]-2,3,7,8-TCDD with rat cytosolic receptor protein and
a series of substituted 4-biphenyl trifluorides.
with n = 11, s = 0.557, r = 0.942. The value AB5 iS
one of the steric parameters that represent the maxi-
mum width ofthe substituents from the axis connecting
the 4'-substituent with the rest of the molecule. AB, is
the value relative to that ofhydrogen [B5(X) - B5(H)].
Although the standard deviation is large, each term is
statistically significant (> 95%). The results also show
that the AHH induction activity is linearly related to
receptor binding (i.e., see Figs. 8 and 9) and the mag-
nitude (2.132) ofthe coefficient oflog (1/EC50) indicates
that enzyme induction is abouttwo times more sensitive
than receptorbindingto the structural variations ofthe
4'-substituents. The AHH induction is also dependent
parabolically with the maximum width of the substi-
tuent X, the optimum width being 1.4, 'Which is close
to the value ofthe NO2and CF3 substituents. This sug-
gests that the interaction ofthe ligand:receptor protein
complex with the nuclear receptor site is dependent on
the conformation of this complex which in turn is gov-
erned by the size of the 4'-X substituent.
The importance of the size of the substituents is ev-
ident in the receptor binding affinities of a series of
halogenated biphenyls which contain two vicinal meta
andPara (4-) substituents in one ofthe phenylrings.
Figures 10 and 11 sumnmarize the competitive binding
affinities of the 3,4-dichloro-, 3,4-dibromo-, and 3,4-
diiodo-4'-biphenyltrifluorides and the 4'-bromo-3,4-
dichloro-, 3,4,4'-dibromo-, and 4'-bromo-3,4-diiodo-3'-
biphenyltrifluorides. The CF3, group was used in both
sets of ligands since this functional group in the 4'-
substituted series of compounds facilitated binding to
theratcytosolicreceptorprotein. Forthe4'-substituted
halogenated biphenyls, the order of binding avidities
forthe substituents was I>Br>Cl, and these data could
be rationalized by the contributions of their respective
electronegativities, lipophilicities and HB capacity.
However, for the 3,4-dihalosubstituted biphenyls, the
order ofbindingavidities forboth series was Br>Cl>I.
This would suggest that steric effects may also play a
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FIGURE 11. Sucrose density gradient analysis after incubation with
10 nM [3H]-2,3,7,8-TCDD with rats cytosolic receptor protein and
a series of substituted 4-bromo-3-biphenyltrifluorides.
role in facilitating ligand substituent interactions with
the receptor protein and that optimal steric, electronic
and lipophilic substituent parameters all contribute to
binding affinity of a ligand for the 2,3,7,8-TCDD cyto-
solic receptor protein. This is also illustrated by the
activity of 3,4,4'-tritrifluoromethylbiphenyl in compe-
titively displacing rH]-2,3,7,8-TCDD fromthe receptor
protein. This ligand contains three substituent groups
that are highly electronegative (a = 0.54) compared to
the Cl, Br and I groups (a = 0.23, 0.23, and 0.18,
respectively); moreover, there are only small differ-
ences intheirhydrophobic r values. However, the com-
petitive binding affinity of this ligand for the receptor
protein was unexpectedly low.
Current research in our laboratory is focused on in
vitro QSAR studies with other substituted halogenated
biphenyls, dibenzofurans and dibenzo-p-dioxins as probes
for investigatingthe structure and function ofthe 2,3,7,8-
TCDD cytosolic receptor protein. This approach is also
being used to compare the relative binding affinities of
ligands to cytosolic receptor protein from species with
different susceptibilities to the effects oftoxic halogen-
ated aryl hydrocarbons.
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